Dendrite Clinical Systems is pleased to announce the prestigious journal, Obesity Surgery, has published a paper highlighting international bariatric surgery practice from the 4th Dendrite/IFSO Global Registry Report. The paper, ‘Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Fourth Dendrite/IFSO Global Registry Report 2018’, (Himpens et al. Obesity Surgery. March 2019.
Dendrite Clinical Systems and The State of Kuwait Ministry of Health,
Dendrite Clinical Systems and The American Vein and Lymphatic Society (formerly the American College of Phlebology) are delighted to announce the launch of the American Vein and Lymphatic Society Registry - a ‘real-time’ clinical database that will identify practice patterns for venous and lymphatic disease diagnosis and treatment across North America.
Dendrite Clinical Systems and the Society for Cardiothoracic Surgery in the UK are pleased to announce the SCTS Conference News 2019 newspaper is now available to view/download. This is the fourth successive year Dendrite has published the newspaper on behalf of the SCTS. The newspaper reports a multitude of presentations from the meeting including the latest and the best information on new technologies and techniques in cardio-thoracic surgery. 
Dendrite Clinical Systems, the publisher of Bariatric News, is pleased to announce issue 39 of the newspaper is now available to view/download. The newspaper reports on research, technology, events and policy in the bariatric specialty, the latest clinical studies, policy changes and product news, the latest meetings and events, interviews prominent bariatric experts, and host debates between specialists on controversial topics.
Dendrite Clinical Systems in pleased to announce its clinical database system has been selected to collect, record and analyse data from the Obesity Research Biobank Syndicate (ORBiS) Registry. ORBiS is a network of multidisciplinary professionals working towards a common goal: to gain novel insights into obesity and weight management, and help translate these findings into improved patient care. 
Dendrite Clinical Systems’ innovative “Intellect Web” software collecting COVID-19 data
Dendrite Clinical Systems’ innovative “Intellect Web” software has been utilised by several national and international organisations to establish web-based registries to collect data from patients with COVID-19.
“Our flexible software has been adapted and utilised across an array of specialities and clinical settings to investigate and record COVID-19 symptoms by teams of international researchers all over the world,” said Dr Peter Walton, Managing Director of Dendrite Clinical Systems. “As a company, we are working with our healthcare partners to enable them to record and report vital patient data and find different treatment strategies to help patients and healthcare systems overcome this devastating virus.”
The company is currently working with an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as part of the CoviDiab project, which is collecting new cases of diabetes in patients with COVID-19. The aim of the CoviDiab Registry is to understand the extent and the characteristics of the manifestations of diabetes in patients with COVID-19, and the best strategies for the treatment and monitoring of affected patients, during and after the pandemic.
Dendrite is also working with the Institute for Health Research (IGES, Berlin) on the Outpatient Treatment of COVID-19 Infections (ABC-19) study that is recording data on treatment of COVID-19 patients to discover more about outpatient course of COVID-19. Study will help establish evidence-based guidelines for outpatient treatment, leading to improved outcomes & prevent unnecessary hospital admissions. Registry collects data from patients using smartphone/tablets via Dendrite’s e-PROMS module (patient-reported outcome measures) allowing patients who are isolating to remotely enter their data directly into the registry at their own convenience – 1st data are expected at the end of 2nd quarter of 2021.
Last year, our software was used in the Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste (FORECAST) study, led by Professor Rachel Batterham from the University College London and the University College London Hospitals NHS Foundation Trust, London, UK. The outcomes from the FORECAST study was the first to confirm that the loss of smell and/or taste are highly-reliable indicators that someone is likely to have Covid-19. The study also utilised our ePROMs software to collect data directly from patients.
Dendrite can provide you with a clinical software solution to help you collect your #COVID-19 data. Contact us today to learn more.
